Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 164

1.

Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE).

Caprio M, Infante M, Moriconi E, Armani A, Fabbri A, Mantovani G, Mariani S, Lubrano C, Poggiogalle E, Migliaccio S, Donini LM, Basciani S, Cignarelli A, Conte E, Ceccarini G, Bogazzi F, Cimino L, Condorelli RA, La Vignera S, Calogero AE, Gambineri A, Vignozzi L, Prodam F, Aimaretti G, Linsalata G, Buralli S, Monzani F, Aversa A, Vettor R, Santini F, Vitti P, Gnessi L, Pagotto U, Giorgino F, Colao A, Lenzi A; Cardiovascular Endocrinology Club of the Italian Society of Endocrinology.

J Endocrinol Invest. 2019 May 20. doi: 10.1007/s40618-019-01061-2. [Epub ahead of print]

PMID:
31111407
2.

Diabetes mellitus induced by somatostatin analogue therapy is not permanent in acromegalic patients.

Cappellani D, Urbani C, Sardella C, Scattina I, Marconcini G, Lupi I, Manetti L, Marcocci C, Bogazzi F.

Endocrinol Diabetes Metab. 2018 Oct 5;2(1):e00033. doi: 10.1002/edm2.33. eCollection 2019 Jan.

3.

Persisting Embryonal Infundibular Recess (PEIR): Two Case Reports and Systematic Literature Review.

Belotti F, Lupi I, Cosottini M, Ambrosi C, Gasparotti R, Bogazzi F, Fontanella MM, Doglietto F.

J Clin Endocrinol Metab. 2018 Jul 1;103(7):2424-2429. doi: 10.1210/jc.2018-00437.

PMID:
29788483
4.

2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction.

Bartalena L, Bogazzi F, Chiovato L, Hubalewska-Dydejczyk A, Links TP, Vanderpump M.

Eur Thyroid J. 2018 Mar;7(2):55-66. doi: 10.1159/000486957. Epub 2018 Feb 14.

5.

Correction to: Pegvisomant in acromegaly: an update.

Giustina A, Arnaldi G, Bogazzi F, Cannavò S, Colao A, De Marinis L, De Menis E, Degli Uberti E, Giorgino F, Grottoli S, Lania AG, Maffei P, Pivonello R, Ghigo E.

J Endocrinol Invest. 2018 Feb;41(2):267. doi: 10.1007/s40618-017-0800-1.

PMID:
29285678
6.

Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features.

Pardi E, Borsari S, Saponaro F, Bogazzi F, Urbani C, Mariotti S, Pigliaru F, Satta C, Pani F, Materazzi G, Miccoli P, Grantaliano L, Marcocci C, Cetani F.

PLoS One. 2017 Oct 16;12(10):e0186485. doi: 10.1371/journal.pone.0186485. eCollection 2017.

7.

Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis.

Lupi I, Cosottini M, Caturegli P, Manetti L, Urbani C, Cappellani D, Scattina I, Martino E, Marcocci C, Bogazzi F.

Eur J Endocrinol. 2017 Aug;177(2):127-135. doi: 10.1530/EJE-17-0123.

PMID:
28626085
8.

[Amiodarone-induced thyrotoxicosis].

Bogazzi F, Tomisti L, Di Bello V, Martino E.

G Ital Cardiol (Rome). 2017 Mar;18(3):219-229. doi: 10.1714/2674.27399. Review. Italian.

PMID:
28398380
9.

Pegvisomant in acromegaly: an update.

Giustina A, Arnaldi G, Bogazzi F, Cannavò S, Colao A, De Marinis L, De Menis E, Degli Uberti E, Giorgino F, Grottoli S, Lania AG, Maffei P, Pivonello R, Ghigo E.

J Endocrinol Invest. 2017 Jun;40(6):577-589. doi: 10.1007/s40618-017-0614-1. Epub 2017 Feb 7. Review. Erratum in: J Endocrinol Invest. 2017 Dec 28;:.

10.

Disease activity and lifestyle influence comorbidities and cardiovascular events in patients with acromegaly.

Sardella C, Cappellani D, Urbani C, Manetti L, Marconcini G, Tomisti L, Lupi I, Rossi G, Scattina I, Lombardi M, Di Bello V, Marcocci C, Martino E, Bogazzi F.

Eur J Endocrinol. 2016 Nov;175(5):443-53. doi: 10.1530/EJE-16-0562. Epub 2016 Aug 15.

PMID:
27528501
11.

The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis.

Tomisti L, Urbani C, Rossi G, Latrofa F, Sardella C, Manetti L, Lupi I, Marcocci C, Bartalena L, Curzio O, Martino E, Bogazzi F.

J Endocrinol Invest. 2016 May;39(5):585-91. doi: 10.1007/s40618-015-0426-0. Epub 2016 Jan 13.

PMID:
26759156
12.

Divergent Effects of Dioxin- or Non-Dioxin-Like Polychlorinated Biphenyls on the Apoptosis of Primary Cell Culture from the Mouse Pituitary Gland.

Raggi F, Russo D, Urbani C, Sardella C, Manetti L, Cappellani D, Lupi I, Tomisti L, Martino E, Marcocci C, Bogazzi F.

PLoS One. 2016 Jan 11;11(1):e0146729. doi: 10.1371/journal.pone.0146729. eCollection 2016.

13.

Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas.

Losa M, Bogazzi F, Cannavo S, Ceccato F, Curtò L, De Marinis L, Iacovazzo D, Lombardi G, Mantovani G, Mazza E, Minniti G, Nizzoli M, Reni M, Scaroni C.

J Neurooncol. 2016 Feb;126(3):519-25. doi: 10.1007/s11060-015-1991-y. Epub 2015 Nov 27.

PMID:
26614517
14.

Does pegvisomant treatment expertise improve control of resistant acromegaly? The Italian ACROSTUDY experience.

Cannavo S, Bogazzi F, Colao A, De Marinis L, Maffei P, Gomez R, Graziano E, Monterubbianesi M, Grottoli S; “Italian Acrostudy Group”.

J Endocrinol Invest. 2015 Oct;38(10):1099-109. doi: 10.1007/s40618-015-0289-4. Epub 2015 Apr 28.

PMID:
25916431
15.

Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET.

Lombardi M, De Lio N, Funel N, Sardella C, Russo D, Urbani C, Rossi G, Campani D, Martino E, Marcocci C, Boggi U, Bogazzi F.

J Endocrinol Invest. 2015 Jun;38(6):605-13. doi: 10.1007/s40618-014-0219-x. Epub 2014 Dec 12.

PMID:
25501604
16.

Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guideline.

Giustina A, Ambrosio MR, Beck Peccoz P, Bogazzi F, Cannavo' S, De Marinis L, De Menis E, Grottoli S, Pivonello R.

J Endocrinol Invest. 2014 Oct;37(10):1017-30. doi: 10.1007/s40618-014-0146-x. Epub 2014 Sep 23. No abstract available.

17.

Lower prolactin levels during cabergoline treatment are associated to tumor shrinkage in prolactin secreting pituitary adenoma.

Lombardi M, Lupi I, Cosottini M, Rossi G, Manetti L, Raffaelli V, Sardella C, Martino E, Bogazzi F.

Horm Metab Res. 2014 Dec;46(13):939-42. doi: 10.1055/s-0034-1389925. Epub 2014 Sep 17.

PMID:
25230324
18.

ACROSTUDY: the Italian experience.

Grottoli S, Maffei P, Bogazzi F, Cannavò S, Colao A, Ghigo E, Gomez R, Graziano E, Monterubbianesi M, Jonsson P, De Marinis L.

Endocrine. 2015 Feb;48(1):334-41. doi: 10.1007/s12020-014-0393-9. Epub 2014 Aug 23.

PMID:
25150035
19.

A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (AIP) gene in an Italian family with gigantism.

Urbani C, Russo D, Raggi F, Lombardi M, Sardella C, Scattina I, Lupi I, Manetti L, Tomisti L, Marcocci C, Martino E, Bogazzi F.

J Endocrinol Invest. 2014 Oct;37(10):949-55. doi: 10.1007/s40618-014-0123-4. Epub 2014 Jul 5.

PMID:
24996936
20.

The onset time of amiodarone-induced thyrotoxicosis (AIT) depends on AIT type.

Tomisti L, Rossi G, Bartalena L, Martino E, Bogazzi F.

Eur J Endocrinol. 2014 Sep;171(3):363-8. doi: 10.1530/EJE-14-0267. Epub 2014 Jun 16.

PMID:
24935933

Supplemental Content

Loading ...
Support Center